HMOX1 and irritable bowel syndrome: This study provides novel evidence for the therapeutic potential of BMSC-Exos in alleviating chronic visceral hyperalgesia and anxiety-like behaviors in a rat model of IBS, mediated through activation of the Nrf-2/HO-1 antioxidant pathway.